Legal News

CMA provisionally finds Pfizer and Flynn illegally overcharged for drugs

Published on: 05 August 2021
Published by LNB News

LNB News 05/08/2021

Document Information

Issue Date: 05 August 2021

Published Date: 05 August 2021

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The Competition and Markets Authority (CMA) has reached a Statement of Objections, provisionally finding that Pfizer and Flynn broke competition law by overcharging the NHS for anti-epilepsy drugs. Pfizer and Flynn allegedly rebranded the drug, so it was not subject to price regulation, leading to NHS spending on the drug to rise from £2m in 2012 to £50m in 2013.

Popular documents